Report cover image

Global Pediatric Vaccines Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 200 Pages
SKU # APRC20280713

Description

Summary

According to APO Research, the global Pediatric Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Pediatric Vaccines market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Pediatric Vaccines market include Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, S K Chemicals and Serum Institute of India, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pediatric Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pediatric Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Pediatric Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pediatric Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pediatric Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pediatric Vaccines sales, projected growth trends, production technology, application and end-user industry.

Pediatric Vaccines Segment by Company

Bavarian Nordic
Bharat Biotech
Crucell
Dynavax
LG Life Sciences
Lupin
Mitsubishi Tanabe Pharma
S K Chemicals
Serum Institute of India
Sinovac Biotech
AstraZeneca
Baxter
GlaxoSmithKline
Pfizer
Merck
Novartis
Sanofi
Shenzhen Kangtai Biological Products
Takeda Pharmaceutical
Janssen
Pediatric Vaccines Segment by Type

Meningococcal Diseases
Influenza
Hepatitis
Pneumococcal Diseases
Diphtheria
Others
Pediatric Vaccines Segment by Application

Infant
Newborn
Dolescent
Child
Pediatric Vaccines Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Pediatric Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pediatric Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pediatric Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Pediatric Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pediatric Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pediatric Vaccines industry.
Chapter 3: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pediatric Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

200 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pediatric Vaccines Sales Value (2020-2031)
1.2.2 Global Pediatric Vaccines Sales Volume (2020-2031)
1.2.3 Global Pediatric Vaccines Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Pediatric Vaccines Market Dynamics
2.1 Pediatric Vaccines Industry Trends
2.2 Pediatric Vaccines Industry Drivers
2.3 Pediatric Vaccines Industry Opportunities and Challenges
2.4 Pediatric Vaccines Industry Restraints
3 Pediatric Vaccines Market by Company
3.1 Global Pediatric Vaccines Company Revenue Ranking in 2024
3.2 Global Pediatric Vaccines Revenue by Company (2020-2025)
3.3 Global Pediatric Vaccines Sales Volume by Company (2020-2025)
3.4 Global Pediatric Vaccines Average Price by Company (2020-2025)
3.5 Global Pediatric Vaccines Company Ranking (2023-2025)
3.6 Global Pediatric Vaccines Company Manufacturing Base and Headquarters
3.7 Global Pediatric Vaccines Company Product Type and Application
3.8 Global Pediatric Vaccines Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Pediatric Vaccines Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Pediatric Vaccines Market by Type
4.1 Pediatric Vaccines Type Introduction
4.1.1 Meningococcal Diseases
4.1.2 Influenza
4.1.3 Hepatitis
4.1.4 Pneumococcal Diseases
4.1.5 Diphtheria
4.1.6 Others
4.2 Global Pediatric Vaccines Sales Volume by Type
4.2.1 Global Pediatric Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pediatric Vaccines Sales Volume by Type (2020-2031)
4.2.3 Global Pediatric Vaccines Sales Volume Share by Type (2020-2031)
4.3 Global Pediatric Vaccines Sales Value by Type
4.3.1 Global Pediatric Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pediatric Vaccines Sales Value by Type (2020-2031)
4.3.3 Global Pediatric Vaccines Sales Value Share by Type (2020-2031)
5 Pediatric Vaccines Market by Application
5.1 Pediatric Vaccines Application Introduction
5.1.1 Infant
5.1.2 Newborn
5.1.3 Dolescent
5.1.4 Child
5.2 Global Pediatric Vaccines Sales Volume by Application
5.2.1 Global Pediatric Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pediatric Vaccines Sales Volume by Application (2020-2031)
5.2.3 Global Pediatric Vaccines Sales Volume Share by Application (2020-2031)
5.3 Global Pediatric Vaccines Sales Value by Application
5.3.1 Global Pediatric Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pediatric Vaccines Sales Value by Application (2020-2031)
5.3.3 Global Pediatric Vaccines Sales Value Share by Application (2020-2031)
6 Pediatric Vaccines Regional Sales and Value Analysis
6.1 Global Pediatric Vaccines Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Pediatric Vaccines Sales by Region (2020-2031)
6.2.1 Global Pediatric Vaccines Sales by Region: 2020-2025
6.2.2 Global Pediatric Vaccines Sales by Region (2026-2031)
6.3 Global Pediatric Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Pediatric Vaccines Sales Value by Region (2020-2031)
6.4.1 Global Pediatric Vaccines Sales Value by Region: 2020-2025
6.4.2 Global Pediatric Vaccines Sales Value by Region (2026-2031)
6.5 Global Pediatric Vaccines Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Pediatric Vaccines Sales Value (2020-2031)
6.6.2 North America Pediatric Vaccines Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Pediatric Vaccines Sales Value (2020-2031)
6.7.2 Europe Pediatric Vaccines Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Pediatric Vaccines Sales Value (2020-2031)
6.8.2 Asia-Pacific Pediatric Vaccines Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Pediatric Vaccines Sales Value (2020-2031)
6.9.2 South America Pediatric Vaccines Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Pediatric Vaccines Sales Value (2020-2031)
6.10.2 Middle East & Africa Pediatric Vaccines Sales Value Share by Country, 2024 VS 2031
7 Pediatric Vaccines Country-level Sales and Value Analysis
7.1 Global Pediatric Vaccines Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Pediatric Vaccines Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Pediatric Vaccines Sales by Country (2020-2031)
7.3.1 Global Pediatric Vaccines Sales by Country (2020-2025)
7.3.2 Global Pediatric Vaccines Sales by Country (2026-2031)
7.4 Global Pediatric Vaccines Sales Value by Country (2020-2031)
7.4.1 Global Pediatric Vaccines Sales Value by Country (2020-2025)
7.4.2 Global Pediatric Vaccines Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.5.2 USA Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.6.2 Canada Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.8.2 Germany Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.9.2 France Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.9.3 France Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.11.2 Italy Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.12.2 Spain Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.13.2 Russia Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.16.2 China Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.16.3 China Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.17.2 Japan Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.19.2 India Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.19.3 India Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.20.2 Australia Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.24.2 Chile Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.26.2 Peru Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.28.2 Israel Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.29.2 UAE Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.31.2 Iran Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Pediatric Vaccines Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Pediatric Vaccines Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Pediatric Vaccines Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Bavarian Nordic
8.1.1 Bavarian Nordic Comapny Information
8.1.2 Bavarian Nordic Business Overview
8.1.3 Bavarian Nordic Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.1.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
8.1.5 Bavarian Nordic Recent Developments
8.2 Bharat Biotech
8.2.1 Bharat Biotech Comapny Information
8.2.2 Bharat Biotech Business Overview
8.2.3 Bharat Biotech Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.2.4 Bharat Biotech Pediatric Vaccines Product Portfolio
8.2.5 Bharat Biotech Recent Developments
8.3 Crucell
8.3.1 Crucell Comapny Information
8.3.2 Crucell Business Overview
8.3.3 Crucell Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.3.4 Crucell Pediatric Vaccines Product Portfolio
8.3.5 Crucell Recent Developments
8.4 Dynavax
8.4.1 Dynavax Comapny Information
8.4.2 Dynavax Business Overview
8.4.3 Dynavax Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.4.4 Dynavax Pediatric Vaccines Product Portfolio
8.4.5 Dynavax Recent Developments
8.5 LG Life Sciences
8.5.1 LG Life Sciences Comapny Information
8.5.2 LG Life Sciences Business Overview
8.5.3 LG Life Sciences Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.5.4 LG Life Sciences Pediatric Vaccines Product Portfolio
8.5.5 LG Life Sciences Recent Developments
8.6 Lupin
8.6.1 Lupin Comapny Information
8.6.2 Lupin Business Overview
8.6.3 Lupin Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.6.4 Lupin Pediatric Vaccines Product Portfolio
8.6.5 Lupin Recent Developments
8.7 Mitsubishi Tanabe Pharma
8.7.1 Mitsubishi Tanabe Pharma Comapny Information
8.7.2 Mitsubishi Tanabe Pharma Business Overview
8.7.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.7.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
8.7.5 Mitsubishi Tanabe Pharma Recent Developments
8.8 S K Chemicals
8.8.1 S K Chemicals Comapny Information
8.8.2 S K Chemicals Business Overview
8.8.3 S K Chemicals Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.8.4 S K Chemicals Pediatric Vaccines Product Portfolio
8.8.5 S K Chemicals Recent Developments
8.9 Serum Institute of India
8.9.1 Serum Institute of India Comapny Information
8.9.2 Serum Institute of India Business Overview
8.9.3 Serum Institute of India Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.9.4 Serum Institute of India Pediatric Vaccines Product Portfolio
8.9.5 Serum Institute of India Recent Developments
8.10 Sinovac Biotech
8.10.1 Sinovac Biotech Comapny Information
8.10.2 Sinovac Biotech Business Overview
8.10.3 Sinovac Biotech Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.10.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
8.10.5 Sinovac Biotech Recent Developments
8.11 AstraZeneca
8.11.1 AstraZeneca Comapny Information
8.11.2 AstraZeneca Business Overview
8.11.3 AstraZeneca Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.11.4 AstraZeneca Pediatric Vaccines Product Portfolio
8.11.5 AstraZeneca Recent Developments
8.12 Baxter
8.12.1 Baxter Comapny Information
8.12.2 Baxter Business Overview
8.12.3 Baxter Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.12.4 Baxter Pediatric Vaccines Product Portfolio
8.12.5 Baxter Recent Developments
8.13 GlaxoSmithKline
8.13.1 GlaxoSmithKline Comapny Information
8.13.2 GlaxoSmithKline Business Overview
8.13.3 GlaxoSmithKline Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.13.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
8.13.5 GlaxoSmithKline Recent Developments
8.14 Pfizer
8.14.1 Pfizer Comapny Information
8.14.2 Pfizer Business Overview
8.14.3 Pfizer Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.14.4 Pfizer Pediatric Vaccines Product Portfolio
8.14.5 Pfizer Recent Developments
8.15 Merck
8.15.1 Merck Comapny Information
8.15.2 Merck Business Overview
8.15.3 Merck Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.15.4 Merck Pediatric Vaccines Product Portfolio
8.15.5 Merck Recent Developments
8.16 Novartis
8.16.1 Novartis Comapny Information
8.16.2 Novartis Business Overview
8.16.3 Novartis Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.16.4 Novartis Pediatric Vaccines Product Portfolio
8.16.5 Novartis Recent Developments
8.17 Sanofi
8.17.1 Sanofi Comapny Information
8.17.2 Sanofi Business Overview
8.17.3 Sanofi Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.17.4 Sanofi Pediatric Vaccines Product Portfolio
8.17.5 Sanofi Recent Developments
8.18 Shenzhen Kangtai Biological Products
8.18.1 Shenzhen Kangtai Biological Products Comapny Information
8.18.2 Shenzhen Kangtai Biological Products Business Overview
8.18.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.18.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
8.18.5 Shenzhen Kangtai Biological Products Recent Developments
8.19 Takeda Pharmaceutical
8.19.1 Takeda Pharmaceutical Comapny Information
8.19.2 Takeda Pharmaceutical Business Overview
8.19.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.19.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
8.19.5 Takeda Pharmaceutical Recent Developments
8.20 Janssen
8.20.1 Janssen Comapny Information
8.20.2 Janssen Business Overview
8.20.3 Janssen Pediatric Vaccines Sales, Value and Gross Margin (2020-2025)
8.20.4 Janssen Pediatric Vaccines Product Portfolio
8.20.5 Janssen Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pediatric Vaccines Value Chain Analysis
9.1.1 Pediatric Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pediatric Vaccines Sales Mode & Process
9.2 Pediatric Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pediatric Vaccines Distributors
9.2.3 Pediatric Vaccines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.